Harvard Bioscience sees Q4 revenue $23M-$26M, consensus $28.5M
The Fly

Harvard Bioscience sees Q4 revenue $23M-$26M, consensus $28.5M

Given the challenging market environment, the company now expects Q4 2024 revenues of $23 to $26 million. The Company expects Q4 2024 gross margins of approximately 59% to 60% and adjusted EBITDA margin in the mid-teens.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App